TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PTHS

Pelthos Therapeutics Inc.

Healthcare · Biotechnology

21.30$ -4.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Pelthos Therapeutics Inc. (PTHS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PTHS
Line item 2021 2022 2023 2024 2025
-1.6 -1.6 -1.0 -5.8 -23
– – – 0.0 2.4
0.0 0.1 1.7 1.8 5.5
-0.8 0.6 2.1 0.0 -6.1
0.0 0.0 0.0 0.0 0.1
– – – – -5.2
– – 0.0 -0.2 0.0
0.0 0.4 0.8 0.3 18
1.6 1.6 1.0 6.2 45
0.0 0.1 0.0 0.4 18
-1.6 -1.6 -1.0 -5.8 -23

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?